Langerhans cell histiocytosis (LCH) is a myeloid neoplasm of mixed cellularity, which is characterized by activating mutations in the mitogen-activated protein kinase (MAPK) pathway (1). Here, WNK2 is linked to Langerhans cell histiocytosis.